EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease

Jinwei Tian, Zhuozhong Wang, Yan Wang, Fan Wang, Xiang Peng, Jiandong Xiao, Chunjie Li, Xinyu Hou, Qian Tong, Xi Yu, Guangren Gao, Peng Zhao und 20 weitere

New England Journal of Medicine · 16.07.2026 · 395 (3) · 233-242

DOI: 10.1056/nejmoa2517588 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift New England Journal of Medicine, erschienen am 16.07.2026. Verfasst von Jinwei Tian und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Aspirin, Clopidogrel, Coronary Artery Disease, Dual Anti-Platelet Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Society of Cardiology Clinical Research Special Fund Project, the Tou-Yan Innovation Team Program of the Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinClopidogrelCoronary Artery DiseaseDual Anti-Platelet TherapyHemorrhagePlatelet Aggregation InhibitorsAdultAgedFemaleHumansMaleMiddle AgedCardiovascular DiseasesDrug Administration ScheduleDrug-Eluting StentsFollow-Up StudiesKaplan-Meier EstimateMyocardial InfarctionStrokeChinaYoung AdultTreatment Outcome

Substanzen

AspirinClopidogrelPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • State Key Laboratory of Frigid Zone Cardiovascular Diseases, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Heilongjiang Provincial Key Laboratory of Panvascular Disease, Harbin, China.
  • Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Harrison International Peace Hospital, Hengshui, China.
  • Tian Jin Chest Hospital, Tianjin, China.

ORCID-Profile: Gregg W Stone

Förderung

  • National Natural Science Foundation of China
  • Chinese Society of Cardiology Clinical Research Special Fund Project
  • the Tou-Yan Innovation Team Program of the Heilongjiang Province
  • Lepu Medical Technology (Beijing) Co., Ltd

Zitieren

APA

Tian, J., Wang, Z., Wang, Y., Wang, F., Peng, X., Xiao, J., Li, C., Hou, X., Tong, Q., Yu, X., Gao, G., Zhao, P., Zhao, J., Liu, Y., Qin, Z., Lu, H., Zhang, S., Li, S., Weng, Z., …, & DAPT-MVD Trial Investigators (2026). Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease. New England Journal of Medicine, 395(3), 233-242. https://doi.org/10.1056/nejmoa2517588

Vancouver

Tian J, Wang Z, Wang Y, Wang F, Peng X, Xiao J, et al. Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease. New England Journal of Medicine. 2026;395(3):233-242. doi:10.1056/nejmoa2517588

BibTeX
@article{Tian2026,
  author = {Tian, Jinwei and Wang, Zhuozhong and Wang, Yan and Wang, Fan and Peng, Xiang and Xiao, Jiandong and Li, Chunjie and Hou, Xinyu and Tong, Qian and Yu, Xi and Gao, Guangren and Zhao, Peng and Zhao, Jie and Liu, Ying and Qin, Zhexue and Lu, Haijing and Zhang, Shujiang and Li, Shengli and Weng, Zhiyuan and Tang, Huifang and He, Yuquan and Zhang, Chunpeng and Liu, Yong and Jiang, Jun and Zhang, Jinying and Cai, Lei and Xiu, Lili and Mintz, Gary S and Wang, Duolao and Stone, Gregg W and Yu, Bo and DAPT-MVD Trial Investigators, DAPT-MVD Trial Investigators},
  title = {Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {3},
  pages = {233--242},
  doi = {10.1056/nejmoa2517588}
}
Kostenlos starten →